A detailed history of West End Advisors, LLC transactions in Insulet Corp stock. As of the latest transaction made, West End Advisors, LLC holds 1 shares of PODD stock, worth $263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$263
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

BUY
$154.67 - $290.89 $154 - $290
1 New
1 $0
Q1 2023

Apr 28, 2023

BUY
$276.36 - $326.03 $276 - $326
1 New
1 $0

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.